Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The study shall prove whether treatment of irritable bowel syndrome with Iberogast is superior to placebo regarding the main criterium \"pain\"
Epistemonikos ID: 93d3658c9b0b8f9d5620ed2940be3ff5f855e2df
First added on: May 11, 2024